Technical Analysis for BCDA - Biocardia Inc.

Grade Last Price % Change Price Change
grade D 1.05 -16.00% -0.2000
BCDA closed down 16.0 percent on Thursday, May 23, 2019, on 2.88 times normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical BCDA trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Fell Below 20 DMA Bearish 0.00%
Stochastic Sell Signal Bearish 0.00%
Wide Range Bar Range Expansion 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -16.00%
Narrow Range Bar Range Contraction -16.00%
Overbought Stochastic Strength -16.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -16.00%
Narrow Range Bar Range Contraction -16.00%
Stochastic Reached Overbought Strength -16.00%

Older signals for BCDA ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
BioCardia, Inc., formerly Tiger X Medical, Inc., is a clinical-stage regenerative medicine company. The Company is engaged in developing therapeutics for cardiovascular diseases. The Company's lead therapeutic candidate is the CardiAMP Cell Therapy System (CardiAMP). It focuses on the Phase III trial for CardiAMP in ischemic systolic heart failure. The Company also offers CardiALLO Cell Therapy System (CardiALLO), an allogeneic off the shelf mesenchymal stem cell product candidate from other donors. It focuses on the Phase II trial for CardiALLO for the treatment of ischemic systolic heart failure. The Company focuses on various fields of autologous and allogeneic cell-based therapies to manage the lives of patients with cardiovascular conditions. CardiAMP is a therapeutic treatment that includes a companion diagnostic. It consists of a cell potency screening test, a point of care cell processing platform and a biotherapeutic delivery system.
Biotechnology Branches Of Biology Life Sciences Biology Stem Cells Regenerative Medicine Cell Biology Cell Therapy Therapy Cardiovascular Diseases Regenerative Biomedicine Heart Failure Stem Cell Therapy Mesoblast
Is BCDA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 3.58
52 Week Low 0.9
Average Volume 5,134
200-Day Moving Average 1.6377
50-Day Moving Average 1.2494
20-Day Moving Average 1.1441
10-Day Moving Average 1.1463
Average True Range 0.0982
ADX 20.73
+DI 25.2928
-DI 39.2958
Chandelier Exit (Long, 3 ATRs ) 1.0254
Chandelier Exit (Short, 3 ATRs ) 1.1946
Upper Bollinger Band 1.3047
Lower Bollinger Band 0.9835
Percent B (%b) 0.21
BandWidth 28.074469
MACD Line -0.0231
MACD Signal Line -0.0357
MACD Histogram 0.0126
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.3500
Resistance 3 (R3) 1.3833 1.3167 1.3000
Resistance 2 (R2) 1.3167 1.2403 1.3000 1.2833
Resistance 1 (R1) 1.1833 1.1931 1.1500 1.1500 1.2667
Pivot Point 1.1167 1.1167 1.1000 1.1000 1.1167
Support 1 (S1) 0.9833 1.0403 0.9500 0.9500 0.8333
Support 2 (S2) 0.9167 0.9931 0.9000 0.8167
Support 3 (S3) 0.7833 0.9167 0.8000
Support 4 (S4) 0.7500